Fundraising Fox
AlgometRx
Washington, US · Founded 2015 · Delaware corporation
Find your way into AlgometRx
Sign up to see every warm intro you have to AlgometRx
- Paths you didn't know you had: your email and LinkedIn already hold routes to the AlgometRx team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
AlgometRx develops the Nociometer, a medical device that analyzes pupil dilation in response to neuroselective stimulation to objectively characterize pain type, intensity, and the effect of analgesics. Spun out of Children's National Hospital, its technology serves clinicians for pain assessment and treatment decisions, and pharmaceutical companies for analgesic drug development.
Founders & leadership
AlgometRx was founded in 2015 by Julia Finkel.
JF
Julia FinkelFounder and Chief Scientific AdvisorJulia Finkel is a board-certified pediatric anesthesiologist and director of Pain Medicine Research & Development at Children's National Hospital's Sheikh Zayed Institute, where she developed technology to objectively measure pain and analgesic effects; she holds a faculty position at George Washington University and founded AlgometRx to commercialize this work.
DG
David GrossExecutive
Reported raises · per SEC filings
Form D private placements$1.9M disclosed across 3 rounds · 2017–2021
▶$875KraisedDec 2021 · 19 investors · Other TechnologyRule 506(b)
▶$875KraisedDec 2021 · 19 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Julia FinkelDirector
- David GrossExecutive Officer, Director
- David HellerDirector
- Offering amount
- $2M
- Amount sold
- $875K
- Minimum investment
- $10K
- First sale
- Sep 2021
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$50KraisedNov 2017 · 12 investors · Other TechnologyRule 506(b)
▶$50KraisedNov 2017 · 12 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- David GrossExecutive Officer, Director
- David HellerDirector
- Julia FinkelDirector
- Offering amount
- $300K
- Amount sold
- $50K
- Minimum investment
- $20K
- First sale
- Nov 2017
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
▶$1MraisedApr 2017 · 7 investors · Other TechnologyRule 506(b)
▶$1MraisedApr 2017 · 7 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Julia FinkelDirector
- David GrossExecutive Officer
- Offering amount
- $1.9M
- Amount sold
- $1M
- Minimum investment
- $25K
- First sale
- Apr 2017
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 3
Ribometrix
CaremetxCareMetx provides a patient access platform for pharmaceutical, biotech, and medical device manufacturers, connecting stakeholders across the treatment journey from benefit verification and prior authorization to therapy onboarding and adherence. Its technology includes a proprietary connection layer, an intelligence engine for next-best-action guidance, and a purpose-built CRM for reimbursement and field coordination workflows.
CareDxCareDx provides innovative solutions and diagnostic tools for transplant patients throughout their pre- and post-transplant journey to improve outcomes and equity in organ transplantation.
Companies working in the same space as AlgometRx.
In the news
Frequently asked questions
- What does AlgometRx do?
- AlgometRx develops the Nociometer, a medical device that analyzes pupil dilation in response to neuroselective stimulation to objectively characterize pain type, intensity, and the effect of analgesics. Spun out of Children's National Hospital, its technology serves clinicians for pain assessment and treatment decisions, and pharmaceutical companies for analgesic drug development.
- Who founded AlgometRx?
- AlgometRx was founded by Julia Finkel in 2015.
- How much funding has AlgometRx raised?
- AlgometRx has disclosed $1.9M raised across 3 rounds.
- Where is AlgometRx headquartered?
- AlgometRx is headquartered in Washington, US.